1. FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
- Author
-
Sharaf, Radwa, Sharaf, Radwa, Pavlick, Dean C, Frampton, Garrett M, Cooper, Maureen, Jenkins, Jacqueline, Danziger, Natalie, Haberberger, James, Alexander, Brian M, Cloughesy, Timothy, Yong, William H, Liau, Linda M, Nghiemphu, Phioanh L, Ji, Matthew, Lai, Albert, Ramkissoon, Shakti H, Albacker, Lee A, Sharaf, Radwa, Sharaf, Radwa, Pavlick, Dean C, Frampton, Garrett M, Cooper, Maureen, Jenkins, Jacqueline, Danziger, Natalie, Haberberger, James, Alexander, Brian M, Cloughesy, Timothy, Yong, William H, Liau, Linda M, Nghiemphu, Phioanh L, Ji, Matthew, Lai, Albert, Ramkissoon, Shakti H, and Albacker, Lee A
- Abstract
BackgroundMolecular profiling of gliomas is vital to ensure diagnostic accuracy, inform prognosis, and identify clinical trial options for primary and recurrent tumors. This study aimed to determine the accuracy of reporting the whole arm 1p19q codeletion status from the FoundationOne platform.MethodsTesting was performed on glioma samples as part of clinical care and analyzed up to 395 cancer-associated genes (including IDH1/2). The whole arm 1p19q codeletion status was predicted from the same assay using a custom research-use only algorithm, which was validated using 463 glioma samples with available fluorescence in-situ hybridization (FISH) data. For 519 patients with available outcomes data, progression-free and overall survival were assessed based on whole arm 1p19q codeletion status derived from sequencing data.ResultsConcordance between 1p19q status based on FISH and our algorithm was 96.7% (449/463) with a positive predictive value (PPV) of 100% and a positive percent agreement (PPA) of 91.0%. All discordant samples were positive for codeletion by FISH and harbored genomic alterations inconsistent with oligodendrogliomas. Median overall survival was 168 months for the IDH1/2 mutant, codeleted group, and 122 months for IDH1/2 mutant-only (hazard ratio (HR): 0.42; P < .05).Conclusions1p19q codeletion status derived from FoundationOne testing is highly concordant with FISH results. Genomic profiling may be a reliable substitute for traditional FISH testing while also providing IDH1/2 status.
- Published
- 2021